NCT00002552View on ClinicalTrials.gov

Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 1993

Primary Completion Date

September 30, 2001

Study Completion Date

October 31, 2003

Conditions
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
Interventions
BIOLOGICAL

filgrastim

BIOLOGICAL

sargramostim

DRUG

carmustine

DRUG

cyclophosphamide

DRUG

cytarabine

DRUG

etoposide

DRUG

leucovorin calcium

DRUG

methotrexate

DRUG

perfosfamide

DRUG

therapeutic hydrocortisone

PROCEDURE

allogeneic bone marrow transplantation

PROCEDURE

autologous bone marrow transplantation

PROCEDURE

in vitro-treated bone marrow transplantation

PROCEDURE

peripheral blood stem cell transplantation

PROCEDURE

syngeneic bone marrow transplantation

RADIATION

radiation therapy

Trial Locations (1)

48201

Barbara Ann Karmanos Cancer Institute, Detroit

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER